Ahn-Gook Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 12:29 pm IST
Share
Ahn-Gook Pharmaceutical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was KRW 0.00049 million compared to KRW 0.00012 million a year ago. Net income was KRW 3,876.99 million compared to KRW 1,410.85 million a year ago. Basic earnings per share from continuing operations was KRW 341 compared to KRW 123 a year ago. Diluted earnings per share from continuing operations was KRW 341 compared to KRW 123 a year ago. Basic earnings per share was KRW 341 compared to KRW 123 a year ago.
For the nine months, sales was KRW 0.00039 million compared to negative sales of KRW 0.00018 million a year ago. Net income was KRW 6,330.45 million compared to KRW 798.4 million a year ago. Basic earnings per share from continuing operations was KRW 556 compared to KRW 70 a year ago. Diluted earnings per share from continuing operations was KRW 556 compared to KRW 70 a year ago. Basic earnings per share was KRW 556 compared to KRW 70 a year ago.
AHN-GOOK PHARMACEUTICAL Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include respiratory agents, gastrointestinal agents, anti-inflammatory, analgesic agents, ophthalmic agents and circulatory system agents. It also provides antibiotic, antifungal drugs, antihyperlipidemic agents, antiallergic drugs, anti-diabetic drugs, urinary system drugs and skin disease remedies. In addition, the Company provides other over the counter (OTC) and ethical (ETC) drugs. The Company distributes its product within domestic market and to overseas markets.